• Love Lund I AB posted no net sales for Apr. 1–Jun. 30, 2026; operating loss narrowed to SEK 825,000 from SEK 837,000 a year earlier.
• Profit after financial items rose to SEK 518,000 from SEK 211,000, despite financial items including write-downs of SEK 1.34 million.
• For Jan. 1–Jun. 30, operating loss widened to SEK 1.7 million from SEK 1.6 million; profit after financial items swung to SEK 78,000 from a loss of SEK 4.02 million.
• Equity per share slipped to SEK 82.1 from SEK 83.65; net asset value was SEK 108.59 per share, with solvency at 99%.
• Quarter activity included profit-taking in BeammWave, new investments including Valkyr Defense and Lead Biologics, and the acquisition of Saga Diagnostics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Love Lund I AB published the original content used to generate this news brief via Cision (Ref. ID: 202607240245BITN____UKPR__SV_20260723-BIT-1246-0) on July 24, 2026, and is solely responsible for the information contained therein.